Zhu et al., 2025 - Google Patents
216 Skin Hydration Outperforms Other Measures in Predicting Age-Related Skin Barrier Changes and Systemic InflammationZhu et al., 2025
View PDF- Document ID
- 1492797358571464298
- Author
- Zhu J
- Kim R
- Doan E
- Stroebel B
- Abuabara K
- Publication year
- Publication venue
- Journal of Investigative Dermatology
External Links
Snippet
Age-related skin barrier decline may contribute to systemic inflammation; however, the best measures of skin barrier function to capture these changes remain unclear. In this cross- sectional study, we compared skin barrier function between young and older adults at the …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ishikawa et al. | Variations in the ceramide profile in different seasons and regions of the body contribute to stratum corneum functions | |
| EP3196647B1 (en) | Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin | |
| Mark et al. | Amino acid composition, including key derivatives of eccrine sweat: potential biomarkers of certain atopic skin conditions | |
| Wilhelm et al. | Surfactant-induced skin irritation and skin repair: evaluation of the acute human irritation model by noninvasive techniques | |
| US9671410B2 (en) | Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin | |
| EP3690439B1 (en) | A noninvasive method for measuring metabolites for skin health | |
| Koppes et al. | Effect of allergens and irritants on levels of natural moisturizing factor and corneocyte morphology | |
| JP6022260B2 (en) | Evaluation method of skin condition | |
| Crisan et al. | Ultrasonographic assessment of the cutaneous changes induced by topical flavonoid therapy | |
| Kunii et al. | Stratum corneum lipid profile and maturation pattern of corneocytes in the outermost layer of fresh scars: the presence of immature corneocytes plays a much more important role in the barrier dysfunction than do changes in intercellular lipids | |
| Pan et al. | Questionnaire and lactic acid sting test play different role on the assessment of sensitive skin: a cross-sectional study | |
| Sato et al. | Fourier transform infrared absorption (FTIR) on dry stratum corneum, corneocyte-lipid interfaces: Experimental and vibrational spectroscopy calculations | |
| Doi et al. | Topical treatment with sacran, a sulfated polysaccharide from Aphanothece sacrum, improves corneocyte‐derived parameters | |
| Kikuchi et al. | Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons | |
| KR20220009424A (en) | How to choose a skin treatment regimen, ingredients and compositions | |
| JP5653783B2 (en) | Evaluation method of water retention ability in skin epidermis | |
| van den Brink et al. | Electrical impedance spectroscopy quantifies skin barrier function in organotypic in vitro epidermis models | |
| Yoshino et al. | 217 Regulatory roles of hyaluronidase 1-mediated hyaluronan metabolism on the epidermal barrier function | |
| Zhu et al. | 216 Skin Hydration Outperforms Other Measures in Predicting Age-Related Skin Barrier Changes and Systemic Inflammation | |
| Lendzion et al. | 221 Peptide complex enriched with copper, zinc and platinum enhances skin cell activity–in vitro, ex vivo and in vivo evaluation of skin rejuvenating potential | |
| Grigorjan et al. | 218 Non-destructive, label-free analysis of the in vitro skin barrier | |
| Bogdanowicz et al. | 219 Epidermal protein signature for anti-aging evaluation: from pharmaco-clinical to molecular mechanisms of a formula containing Retinaldehyde, Niacinamide and Hyaluronic acid. | |
| Nico et al. | 220 In Vivo Assessment of Molecular Penetration and Skin Effects of Topical Products | |
| JP5731598B2 (en) | Evaluation method for rough skin | |
| JP2011083207A (en) | Method for evaluating epidermal turnover and application thereof |